WednesdayAug 16, 2023 11:04 am

QualityStocksNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Bright Future in Advancing Potentially Curative Therapies

Renovaro BioSciences (NASDAQ: RENB), (formerly NASDAQ: ENOB), is focused on advancing treatments for some of the world’s deadliest diseases. In late 2022, the company announced the award of a U.S. patent for its oncology platform, as well as promising early results in studies conducted in conjunction with Dr. Ana Jewett at UCLA. Scientists at the Fred Hutchinson Cancer Center were also, at that time, conducting studies of the company’s HIV platform with expected positive results. “We continue to prioritize the efficient research, development and commercialization of our promising oncology and HIV pipelines,” said the company’s CEO Dr. Mark Dybul. “Enochian’s…

Continue Reading

WednesdayAug 16, 2023 10:32 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Unveils Ultra-High-Performance FIVE RS Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced its newest mode: the ultra-high-performance Mullen FIVE RS EV Crossover. According to the announcement, the newest addition to MULN’s offerings features a top speed of more than 200 mph and can accelerate from 0–60 mph in under two seconds. The FIVE RS is equipped with 800-volt architecture, all-wheel drive, a two-speed gearbox and more than 1,100 horsepower. MULN is planning to showcase the model at this season’s kickoff of its Strikingly Different EV tour, which begins on Aug. 20, 2023, in Austin, Texas. The company noted that because of…

Continue Reading

TuesdayAug 15, 2023 1:57 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Provides Q2 Update Video, Announces New ASR Deployment, Adds Roadshow Date to Calendar

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has released its Second Quarter 2023 Town Hall Update video. The company recorded its Aug. 14, 2023, town hall event; the video is available on the company website for those who were unable to attend the gathering in person. In addition, the company announced the latest deployment of its ASR security solutions. According to the announcement, a K5 ASR has been deployed in North Carolina by KSCP reseller Weatherspoon Enterprises, Inc., a North Carolina-based integrated security services and solutions provider. Weatherspoon offers the…

Continue Reading

TuesdayAug 15, 2023 1:18 pm

QualityStocksNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Committed to Rapid Advancement of Its Proprietary Oncology Platform

Renovaro BioSciences (NASDAQ: RENB), (formerly NASDAQ: ENOB), in late 2022, was awarded a U.S. patent for its proprietary cancer treatment platform that could potentially be used to induce life-long remission from some of the world’s deadliest solid tumors. “We are incredibly excited to have been awarded this patent for Enochian’s allogeneic cell and gene therapy cancer treatment platform, especially following promising early study results,” said the company’s CEO Dr. Mark Dybul. “This technology could be transformative for oncology and for treating some of the world’s deadliest cancers, including pancreatic cancer, which has a five-year survival rate of just 5% to…

Continue Reading

TuesdayAug 15, 2023 12:58 pm

QualityStocksNewsBreaks – GEMXX Corporation (GEMZ) Releases Report of First 2023 Season Gold Production from Snow Creek Mine Site

GEMXX (OTC: GEMZ), a leader in the Ammolite gemstone mine-to-market segment, is reporting the successful completion of its first clean-out and recording of gold production at the Snow Creek Mine site for the 2023 mining season. GEMXX is working in collaboration with Crazy Horse Mining Inc. (“CHMI”) on the Snow Creek Mine project. According to the announcement, the two companies have processed a 4,500-cubic-yard sample of gold-bearing surface ore stockpiled while building the processing site, thereby providing a “positive indication of the resource potential on the property.” The company noted that initial production results, which have yielded 38.73 ounces of…

Continue Reading

TuesdayAug 15, 2023 12:47 pm

QualityStocksNewsBreaks – Correlate Energy Corp. (CIPI) Announces Strong Q2 Results, Eyes Growing Momentum

Correlate (OTCQB: CIPI), a growth-oriented distributed energy company, has announced financial results for the second quarter ended June 30, 2023. Among the highlights, the company reported that it achieved revenue of $4,158,122 in Q2 2023 compared to $236,690 for the same quarter last year. Correlate believes that demand for renewables will continue to grow exponentially and that the need for localized energy systems that can operate independently or in connection with the main power infrastructure, such as microgrids, will play a pivotal role in facilitating the ongoing transition to renewable energy in the United States. “Correlate Energy Corp. is led…

Continue Reading

MondayAug 14, 2023 2:22 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Continues Sales Momentum with Three New Contracts, Takes Roadshow to Pittsburg

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is seeing consistent rising sales; the company just announced the signing of three more contracts. According to the announcement, Knightscope has inked security deals with a third-party logistics (“3PL”) provider in the Midwest; a Central-U.S. regional transit authority and a country club in the Northeast. According to the announcement, the regional 3PL provider is a current KSCP customer that signed its first Knightscope contract last year. The company offers value-added services such as warehousing and distribution, packaging, assembly, and fulfillment and has facilities…

Continue Reading

MondayAug 14, 2023 2:01 pm

QualityStocksNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Q1 2024 Financial Report

IGC Pharma (NYSE American: IGC), a company that develops advanced cannabinoid-based formulations for treating diseases and conditions, including but not limited to Alzheimer's disease, period cramps (dysmenorrhea), premenstrual syndrome ("PMS") and chronic pain, is reporting on its financial and business results for the first quarter of the 2024 fiscal year, the period ended June 30, 2023. Highlights of the report include a 161% increase in net revenue, which totaled approximately $555,000 compared to $212,000 in the same quarter of 2023; continued momentum in the development of IGC’s phase 3 manufacturing facility located on the West Coast; a $12 million line…

Continue Reading

MondayAug 14, 2023 1:41 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Fiscal Q3 Results, Business Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced financial results for its fiscal third quarter for the three and nine months ended June 30, 2023, and provided recent business updates. Among the highlights, the company’s board of directors has authorized a stock buyback program, pursuant to which the company may, until Dec. 31, 2023, purchase up to $25 million in shares of its outstanding common stock. Mullen ended fiscal third quarter on June 30, 2023, with stockholders’ equity of $351.8 million, compared to $157.0 million on Sept 30, 2022, which represents a 124% increase. In addition,…

Continue Reading

MondayAug 14, 2023 12:50 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2023 Results, Presents Updated Findings from Potentially Pivotal Study of Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its financial results for the quarter ended June 30, 2023, provided a corporate update and reiterated upcoming milestones. “We are approaching the most important milestone to date since we launched CNS Pharma. We are just a few months away from reporting topline results from our Berubicin potentially pivotal study interim analysis and, although we do not know what the data looks like at this time, we remain hopeful as we also approach…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered